Background: Hypertension is a prevalent disease in many countries, either developing alone as essential hypertension or passing as co-morbid in atherosclerotic diseases and fibrodysplasia. Hypertension has a variable presentation, with most patients being asymptomatic; clinical signs do occur, such as headaches, and should alert the physician to the possibility of advanced disease or uncontrolled blood pressure. Methods: PubMed database was used for articles selection, and the following keywords were used in the mesh; "Hypertension"[Mesh] and “Evaluation"[Mesh] or "Management"[Mesh] or "Treatment"[Mesh] and “Family Physician” [Mesh]. Many articles on the topic were found, with further restriction by PubMed filters, and with reviewing the titles and abstracts of the articles, the final results were included in this paper. Conclusion: Family physicians should focus on maintaining blood pressure to appropriate levels by combining updated guidelines and clinical judgment. Beta-blockers, thiazides, and angiotensin-converting enzyme inhibitors continue to be the mainstay of treatment in hypertensive diseases; newer novel drugs are being tested with promising results.Background: Hypertension is a prevalent disease in many countries, either developing alone as essential hypertension or passing as co-morbid in atherosclerotic diseases and fibrodysplasia. Hypertension has a variable presentation, with most patients being asymptomatic; clinical signs do occur, such as headaches, and should alert the physician to the possibility of advanced disease or uncontrolled blood pressure. Methods: PubMed database was used for articles selection, and the following keywords were used in the mesh; "Hypertension"[Mesh] and “Evaluation"[Mesh] or "Management"[Mesh] or "Treatment"[Mesh] and “Family Physician” [Mesh]. Many articles on the topic were found, with further restriction by PubMed filters, and with reviewing the titles and abstracts of the articles, the final results were included in this paper. Conclusion: Family physicians should focus on maintaining blood pressure to appropriate levels by combining updated guidelines and clinical judgment. Beta-blockers, thiazides, and angiotensin-converting enzyme inhibitors continue to be the mainstay of treatment in hypertensive diseases; newer novel drugs are being tested with promising results.
IJPRAS
